Moderna files for U.S. authorization to use its COVID-19 vaccine in teens

Published by
Reuters

(Reuters) – Moderna Inc said on Thursday it has filed for U.S. authorization to use its COVID-19 vaccine in adolescents aged 12 through 17, potentially offering healthcare providers and pediatricians an easier-to-store shot ahead of the return-to-school season in the fall. The company is the second drugmaker to seek regulatory nod for use of its vaccine in the age group, as the U.S. tries to vaccinate more young people. Vaccinating children has been considered key to achieving “herd immunity” and while they mostly develop only mild COVID-19 symptoms or no symptoms, younger people still remain …

Read More

Share this Story
Load More Related Articles
Load More In US News

Facebook Comments

Check Also

Sunshine, perfume and other things you need to protect jewellery from

Published by DPA If you want to extend ...

Archives